Hemophilia B: Epidemiology Forecasting Intelligence
Report ID: 228327 | Mar 2019 | No. of Pages: 70
|
Publisher's "Hemophilia B-Epidemiology Forecasting Intelligence" report provides a comprehensive analysis of the Hemophilia B epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.
Our epidemiology services include:
- Incidence and prevalence
- Diagnosis rate, treatment rate and mortality patterns
- Epidemiology-based forecasting and disease trends
- Size of different patient segments in a disease area
- Population based: disease occurrence, co-morbidities and treatment patterns
- Geographic - Regional - Ethnic differences
Along with the epidemiological data, the report also includes:
- Disease overview, causes, symptoms, classification, risk factor, pathophysiology, diagnosis and treatment
- Patient treatment journey
- Treatment algorithm and guidelines
- Assesses the disease risk and burden
- Highlights the unmet needs
- Market driver and barrier
- Growth opportunities and market trend analysis
Methodology
- This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Epidemiology Forecast model analysis by a team of industry experts.
- To generate accurate patient population estimates, utilizes a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
- All of the sources used to generate the data and analysis have been identified in the report.
Note: Systematic review of the epidemiological literature is also provided for full transparency into research and methods.
Our epidemiology services include:
- Incidence and prevalence
- Diagnosis rate, treatment rate and mortality patterns
- Epidemiology-based forecasting and disease trends
- Size of different patient segments in a disease area
- Population based: disease occurrence, co-morbidities and treatment patterns
- Geographic - Regional - Ethnic differences
Along with the epidemiological data, the report also includes:
- Disease overview, causes, symptoms, classification, risk factor, pathophysiology, diagnosis and treatment
- Patient treatment journey
- Treatment algorithm and guidelines
- Assesses the disease risk and burden
- Highlights the unmet needs
- Market driver and barrier
- Growth opportunities and market trend analysis
Methodology
- This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Epidemiology Forecast model analysis by a team of industry experts.
- To generate accurate patient population estimates, utilizes a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
- All of the sources used to generate the data and analysis have been identified in the report.
Note: Systematic review of the epidemiological literature is also provided for full transparency into research and methods.
TABLE OF CONTENTS1. Report Introduction
2. Hemophilia B Epidemiology Overview at a Glance
3. Market Share Distribution of Hemophilia B
4. Disease Background and Overview: Hemophilia B
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Hemophilia B Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Hemophilia B by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Hemophilia B
7.3. Sub-Type Specific cases of Hemophilia B-
7.4. Sex- Specific Cases of Hemophilia B-
7.5. Diagnosed Cases of Hemophilia B
7.6. Treated Cases of Hemophilia B
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Hemophilia B
8.1.3. Sub-Type Specific cases of Hemophilia B-
8.1.4. Sex- Specific Cases of Hemophilia B-
8.1.5. Diagnosed Cases of Hemophilia B
8.1.6. Treated Cases of Hemophilia B
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Hemophilia B
8.2.3. Sub-Type Specific cases of Hemophilia B-
8.2.4. Sex- Specific Cases of Hemophilia B-
8.2.5. Diagnosed Cases of Hemophilia B
8.2.6. Treated Cases of Hemophilia B
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Hemophilia B
8.3.3. Sub-Type Specific cases of Hemophilia B-
8.3.4. Sex- Specific Cases of Hemophilia B-
8.3.5. Diagnosed Cases of Hemophilia B
8.3.6. Treated Cases of Hemophilia B
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Hemophilia B
8.4.3. Sub-Type Specific cases of Hemophilia B-
8.4.4. Sex- Specific Cases of Hemophilia B-
8.4.5. Diagnosed Cases of Hemophilia B
8.4.6. Treated Cases of Hemophilia B
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Hemophilia B
8.5.3. Sub-Type Specific cases of Hemophilia B-
8.5.4. Sex- Specific Cases of Hemophilia B-
8.5.5. Diagnosed Cases of Hemophilia B
8.5.6. Treated Cases of Hemophilia B
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Hemophilia B
9.3. Sub-Type Specific cases of Hemophilia B-
9.4. Sex- Specific Cases of Hemophilia B-
9.5. Diagnosed Cases of Hemophilia B
9.6. Treated Cases of Hemophilia B
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About Publisher
- Indication Specific
Note: Certain sections of the table of contents would vary according to the availability of information.
LIST OF TABLES
Table 1: Total Prevalent/Incident Cases of the Hemophilia B in 7MM
Table 2: Total Prevalent/Incident Cases of the Hemophilia B in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hemophilia B in United States
Table 4: Sub-Type Specific Cases of the Hemophilia B in United States-
Table 5: Sex- Specific Cases of the Hemophilia B in United States-
Table 6: Diagnosed Cases of the Hemophilia B in United States
Table 7: Treated Cases of the Hemophilia B in United States
Table 8: Prevalent/Incident Cases of the Hemophilia B in Germany
Table 9: Sub-Type Specific Cases of the Hemophilia B in Germany-
Table 10: Sex- Specific Cases of the Hemophilia B in Germany-
Table 11: Diagnosed Cases of the Hemophilia B in Germany
Table 12: Treated Cases of the Hemophilia B in Germany
Table 13: Prevalent/Incident Cases of the Hemophilia B in France
Table 14: Sub-Type Specific Cases of the Hemophilia B in France-
Table 15: Sex- Specific Cases of the Hemophilia B in France-
Table 16: Diagnosed Cases of the Hemophilia B in France
Table 17: Treated Cases of the Hemophilia B in France
Table 18: Prevalent/Incident Cases of the Hemophilia B in Italy
Table 19: Sub-Type Specific Cases of the Hemophilia B in Italy-
Table 20: Sex- Specific Cases of the Hemophilia B in Italy-
Table 21: Diagnosed Cases of the Hemophilia B in Italy
Table 22: Treated Cases of the Hemophilia B in Italy
Table 23: Prevalent/Incident Cases of the Hemophilia B in Spain
Table 24: Sub-Type Specific Cases of the Hemophilia B in Spain-
Table 25: Sex- Specific Cases of the Hemophilia B in Spain-
Table 26: Diagnosed Cases of the Hemophilia B in Spain
Table 27: Treated Cases of the Hemophilia B in Spain
Table 28: Prevalent/Incident Cases of the Hemophilia B in UK
Table 29: Sub-Type Specific Cases of the Hemophilia B in UK-
Table 30: Sex- Specific Cases of the Hemophilia B in UK-
Table 31: Diagnosed Cases of the Hemophilia B in UK
Table 32: Treated Cases of the Hemophilia B in UK
Table 33: Prevalent/Incident Cases of the Hemophilia B in Japan
Table 34: Sub-Type Specific Cases of the Hemophilia B in Japan-
Table 35: Sex- Specific Cases of the Hemophilia B in Japan-
Table 36: Diagnosed Cases of the Hemophilia B in Japan
Table 37: Treated Cases of the Hemophilia B in Japan
- Indication Specific
LIST OF FIGURES
Figure 1: Total Prevalent/Incident Cases of the Hemophilia B in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hemophilia B in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hemophilia B in United States
Figure 4: Sub-Type Specific Cases of the Hemophilia B in United States-
Figure 5: Sex- Specific Cases of the Hemophilia B in United States-
Figure 6: Diagnosed Cases of the Hemophilia B in United States
Figure 7: Treated Cases of the Hemophilia B in United States
Figure 8: Prevalent/Incident Cases of the Hemophilia B in Germany
Figure 9: Sub-Type Specific Cases of the Hemophilia B in Germany-
Figure 10: Sex- Specific Cases of the Hemophilia B in Germany-
Figure 11: Diagnosed Cases of the Hemophilia B in Germany
Figure 12: Treated Cases of the Hemophilia B in Germany
Figure 13: Prevalent/Incident Cases of the Hemophilia B in France
Figure 14: Sub-Type Specific Cases of the Hemophilia B in France-
Figure 15: Sex- Specific Cases of the Hemophilia B in France-
Figure 16: Diagnosed Cases of the Hemophilia B in France
Figure 17: Treated Cases of the Hemophilia B in United France
Figure 18: Prevalent/Incident Cases of the Hemophilia B in Italy
Figure 19: Sub-Type Specific Cases of the Hemophilia B in Italy-
Figure 20: Sex- Specific Cases of the Hemophilia B in Italy-
Figure 21: Diagnosed Cases of the Hemophilia B in Italy
Figure 22: Treated Cases of the Hemophilia B in Italy
Figure 23: Prevalent/Incident Cases of the Hemophilia B in Spain
Figure 24: Sub-Type Specific Cases of the Hemophilia B in Spain-
Figure 25: Sex- Specific Cases of the Hemophilia B in Spain-
Figure 26: Diagnosed Cases of the Hemophilia B in Spain
Figure 27: Treated Cases of the Hemophilia B in Spain
Figure 28: Prevalent/Incident Cases of the Hemophilia B in UK
Figure 29: Sub-Type Specific Cases of the Hemophilia B in UK-
Figure 30: Sex- Specific Cases of the Hemophilia B in UK-
Figure 31: Diagnosed Cases of the Hemophilia B in UK
Figure 32: Treated Cases of the Hemophilia B in UK
Figure 33: Prevalent/Incident Cases of the Hemophilia B in Japan
Figure 34: Sub-Type Specific Cases of the Hemophilia B in Japan-
Figure 35: Sex- Specific Cases of the Hemophilia B in Japan-
Figure 36: Diagnosed Cases of the Hemophilia B in Japan
Figure 37: Treated Cases of the Hemophilia B in Japan
- Indication Specific
2. Hemophilia B Epidemiology Overview at a Glance
3. Market Share Distribution of Hemophilia B
4. Disease Background and Overview: Hemophilia B
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Hemophilia B Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Hemophilia B by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Hemophilia B
7.3. Sub-Type Specific cases of Hemophilia B-
7.4. Sex- Specific Cases of Hemophilia B-
7.5. Diagnosed Cases of Hemophilia B
7.6. Treated Cases of Hemophilia B
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Hemophilia B
8.1.3. Sub-Type Specific cases of Hemophilia B-
8.1.4. Sex- Specific Cases of Hemophilia B-
8.1.5. Diagnosed Cases of Hemophilia B
8.1.6. Treated Cases of Hemophilia B
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Hemophilia B
8.2.3. Sub-Type Specific cases of Hemophilia B-
8.2.4. Sex- Specific Cases of Hemophilia B-
8.2.5. Diagnosed Cases of Hemophilia B
8.2.6. Treated Cases of Hemophilia B
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Hemophilia B
8.3.3. Sub-Type Specific cases of Hemophilia B-
8.3.4. Sex- Specific Cases of Hemophilia B-
8.3.5. Diagnosed Cases of Hemophilia B
8.3.6. Treated Cases of Hemophilia B
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Hemophilia B
8.4.3. Sub-Type Specific cases of Hemophilia B-
8.4.4. Sex- Specific Cases of Hemophilia B-
8.4.5. Diagnosed Cases of Hemophilia B
8.4.6. Treated Cases of Hemophilia B
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Hemophilia B
8.5.3. Sub-Type Specific cases of Hemophilia B-
8.5.4. Sex- Specific Cases of Hemophilia B-
8.5.5. Diagnosed Cases of Hemophilia B
8.5.6. Treated Cases of Hemophilia B
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Hemophilia B
9.3. Sub-Type Specific cases of Hemophilia B-
9.4. Sex- Specific Cases of Hemophilia B-
9.5. Diagnosed Cases of Hemophilia B
9.6. Treated Cases of Hemophilia B
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About Publisher
- Indication Specific
Note: Certain sections of the table of contents would vary according to the availability of information.
LIST OF TABLES
Table 1: Total Prevalent/Incident Cases of the Hemophilia B in 7MM
Table 2: Total Prevalent/Incident Cases of the Hemophilia B in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hemophilia B in United States
Table 4: Sub-Type Specific Cases of the Hemophilia B in United States-
Table 5: Sex- Specific Cases of the Hemophilia B in United States-
Table 6: Diagnosed Cases of the Hemophilia B in United States
Table 7: Treated Cases of the Hemophilia B in United States
Table 8: Prevalent/Incident Cases of the Hemophilia B in Germany
Table 9: Sub-Type Specific Cases of the Hemophilia B in Germany-
Table 10: Sex- Specific Cases of the Hemophilia B in Germany-
Table 11: Diagnosed Cases of the Hemophilia B in Germany
Table 12: Treated Cases of the Hemophilia B in Germany
Table 13: Prevalent/Incident Cases of the Hemophilia B in France
Table 14: Sub-Type Specific Cases of the Hemophilia B in France-
Table 15: Sex- Specific Cases of the Hemophilia B in France-
Table 16: Diagnosed Cases of the Hemophilia B in France
Table 17: Treated Cases of the Hemophilia B in France
Table 18: Prevalent/Incident Cases of the Hemophilia B in Italy
Table 19: Sub-Type Specific Cases of the Hemophilia B in Italy-
Table 20: Sex- Specific Cases of the Hemophilia B in Italy-
Table 21: Diagnosed Cases of the Hemophilia B in Italy
Table 22: Treated Cases of the Hemophilia B in Italy
Table 23: Prevalent/Incident Cases of the Hemophilia B in Spain
Table 24: Sub-Type Specific Cases of the Hemophilia B in Spain-
Table 25: Sex- Specific Cases of the Hemophilia B in Spain-
Table 26: Diagnosed Cases of the Hemophilia B in Spain
Table 27: Treated Cases of the Hemophilia B in Spain
Table 28: Prevalent/Incident Cases of the Hemophilia B in UK
Table 29: Sub-Type Specific Cases of the Hemophilia B in UK-
Table 30: Sex- Specific Cases of the Hemophilia B in UK-
Table 31: Diagnosed Cases of the Hemophilia B in UK
Table 32: Treated Cases of the Hemophilia B in UK
Table 33: Prevalent/Incident Cases of the Hemophilia B in Japan
Table 34: Sub-Type Specific Cases of the Hemophilia B in Japan-
Table 35: Sex- Specific Cases of the Hemophilia B in Japan-
Table 36: Diagnosed Cases of the Hemophilia B in Japan
Table 37: Treated Cases of the Hemophilia B in Japan
- Indication Specific
LIST OF FIGURES
Figure 1: Total Prevalent/Incident Cases of the Hemophilia B in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hemophilia B in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hemophilia B in United States
Figure 4: Sub-Type Specific Cases of the Hemophilia B in United States-
Figure 5: Sex- Specific Cases of the Hemophilia B in United States-
Figure 6: Diagnosed Cases of the Hemophilia B in United States
Figure 7: Treated Cases of the Hemophilia B in United States
Figure 8: Prevalent/Incident Cases of the Hemophilia B in Germany
Figure 9: Sub-Type Specific Cases of the Hemophilia B in Germany-
Figure 10: Sex- Specific Cases of the Hemophilia B in Germany-
Figure 11: Diagnosed Cases of the Hemophilia B in Germany
Figure 12: Treated Cases of the Hemophilia B in Germany
Figure 13: Prevalent/Incident Cases of the Hemophilia B in France
Figure 14: Sub-Type Specific Cases of the Hemophilia B in France-
Figure 15: Sex- Specific Cases of the Hemophilia B in France-
Figure 16: Diagnosed Cases of the Hemophilia B in France
Figure 17: Treated Cases of the Hemophilia B in United France
Figure 18: Prevalent/Incident Cases of the Hemophilia B in Italy
Figure 19: Sub-Type Specific Cases of the Hemophilia B in Italy-
Figure 20: Sex- Specific Cases of the Hemophilia B in Italy-
Figure 21: Diagnosed Cases of the Hemophilia B in Italy
Figure 22: Treated Cases of the Hemophilia B in Italy
Figure 23: Prevalent/Incident Cases of the Hemophilia B in Spain
Figure 24: Sub-Type Specific Cases of the Hemophilia B in Spain-
Figure 25: Sex- Specific Cases of the Hemophilia B in Spain-
Figure 26: Diagnosed Cases of the Hemophilia B in Spain
Figure 27: Treated Cases of the Hemophilia B in Spain
Figure 28: Prevalent/Incident Cases of the Hemophilia B in UK
Figure 29: Sub-Type Specific Cases of the Hemophilia B in UK-
Figure 30: Sex- Specific Cases of the Hemophilia B in UK-
Figure 31: Diagnosed Cases of the Hemophilia B in UK
Figure 32: Treated Cases of the Hemophilia B in UK
Figure 33: Prevalent/Incident Cases of the Hemophilia B in Japan
Figure 34: Sub-Type Specific Cases of the Hemophilia B in Japan-
Figure 35: Sex- Specific Cases of the Hemophilia B in Japan-
Figure 36: Diagnosed Cases of the Hemophilia B in Japan
Figure 37: Treated Cases of the Hemophilia B in Japan
- Indication Specific
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. It provides a forward looking perspective on different factors driving or restraining market growth
3. It provides a ten-year forecast assessed on the basis of how the market is expected to grow
4. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segments
Connect With Us
+1-707-633-0404
sales@search4research.com
Related reports
|
|
ECG Management Systems Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |
|
|
Adult Day Care Services Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |
|
|
Virtual Microscopy Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |
|
|
Teledentistry Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |
|
|
Medical Second Opinion Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |